Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Robert Oringer is an angel investor and healthcare industry entrepreneur based in Montreal, Canada. He is known for his work in the diabetes field, having founded CanAm Care, which created Dex4®, a leading brand of nonprescription hypoglycemia treatment products. He is also a Co-Creator and Chairman at Locemia Solutions. Oringer is an active early-stage diabetes investor, with a personal motivation stemming from his two sons being diagnosed with Type 1 diabetes. His investment focus has evolved from treating hypoglycemia to preventing it with innovative solutions.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Robert Oringer's primary investment focus by sector?
- Robert Oringer has concentrated his investments in the Health Tech & Life Sciences sector, with one recorded investment in this area.
- What is Robert Oringer's typical investment stage?
- Robert Oringer primarily invests in the Seed stage, with one recorded investment at this stage.
- Can you name a notable company in Robert Oringer's portfolio?
- A notable company in Robert Oringer's portfolio is RxWare, a B2B and B2C company founded in 2013 that focuses on patient journey gateways.
- When did Robert Oringer make his most recent investment?
- Robert Oringer's most recent recorded investment was in July 2014.
- What is the typical check size for Robert Oringer's investments?
- Robert Oringer's investment range is typically between $550K and $550K.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 1 |
|---|